An aptamer targeting TfR1 enhances ASO delivery to muscle tissue
Warner, M. J.; Kelly, L.; Thakur, R.; Ravichandran, M.; Tomar, D.; Nidhi, N.; Tamraparni, V.; Govindaraj, E.; Samji, P.; Krishna, M.; Kulkarni, A. S.; LEVY, M.
Show abstract
Oligonucleotide based therapeutics continue to rise as a significant class of medicines for the treatment of human disease. However, achieving delivery to non-hepatic tissues remains a challenge in the field. While substantial advances have been realized, largely through the use of antibody or protein based targeting agents to tissues including muscle and the CNS, these large protein agents present complications in synthesis and carry the potential for immune responses. In an effort to identify a simpler, smaller and robust means of delivery, we have generated and evaluated aptamers targeting the human transferrin receptor (hTfR) for the delivery of both ASO and siRNA cargoes to muscle. Using a fully backbone modified anti-TfR aptamer, 36 nt in length, that binds hTfR and does not compete for binding with the natural ligand, transferrin, we evaluated the ability to deliver ASOs to skeletal muscle following systemic delivery. Using optimized linker chemistry, aptamer-ASO conjugates led to >50% target gene knockdown in muscle tissue for up to 42 days following a single dose at 3 mg/kg ASO ([~]11 mg/kg total drug) in mice. Taken as a whole, these results offer significant promise for the use of aptamers in the development of future therapeutics.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Optimizing C14120-based LNPs for in vitro and in vivo mRNA delivery 92%
- A homodimeric aptamer variant generated from ligand-guided selection activates T-cell receptor cluster of differentiation three complex 92%
- Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3 92%
Similar papers in this journal
- Quantifying and Mitigating Motor Phenotypes Induced by Antisense Oligonucleotides in the Central Nervous System 96%
- Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics 94%
- Targeting lipid nanoparticles to the blood brain barrier to ameliorate acute ischemic stroke 93%
Similar papers in this journal
- Dual-targeted nanoparticulate drug delivery systems for enhancing triple-negative breast cancer treatment 93%
- {Pi}-{Pi} Interactions Stabilize PeptoMicelle-Based Formulations of Pretomanid Derivatives Leading to Promising Therapy Against Tuberculosis in Zebrafish and Mouse Models 92%
- Low-frequency ultrasound-mediated blood-brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastoma 92%
Similar papers in this journal
Similar papers in this journal
- Tandem-Cleavage Linkers Improve the In Vivo Stability and Tolerability of Antibody-Drug Conjugates 93%
- Targeted Polymersomes Enable Enhanced Delivery to Peripheral Nerves Post-Injury 92%
- Novel approaches to label the surface of S. aureus with DBCO for click chemistry-mediated deposition of sensitive cargo 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.